tranylcypromine
Tranylcypromine is a monoamine oxidase inhibitor (MAOI) used as an antidepressant. It is non-selective and irreversible, typically marketed under brand names such as Parnate. It is generally reserved for treatment of major depressive disorder that has not responded to other therapies.
The drug acts by inhibiting monoamine oxidase enzymes, MAO-A and MAO-B, in the brain and gut. This
Indications for tranylcypromine include treatment of major depressive disorder, particularly in cases that are resistant to
Pharmacokinetics and duration: tranylcypromine is administered orally and is rapidly absorbed. It is metabolized in the
Safety and interactions: a major safety issue is the risk of hypertensive crisis with ingestion of tyramine-containing